Skip to main content

Table 1 Patient clinical characteristics details

From: Complement activation in multiple sclerosis plaques: an immunohistochemical analysis

Case number Disease status Age at death Sex Death to TPT DD Cause of death
MS055 SPMS 47 F 15 32 Pneumonia
MS058 SPMS 51 F 15 21 MS
MS061 PRMS 56 F 6 >15 Adenocarcinoma
MS064 SPMS 66 M 56 28 Pneumonia
MS128 SPMS 78 F 22 50 Pneumonia
MS179 SPMS 70 F 20 25 Pneumonia
MS306 SPMS 78 M 17 42 Clostridium difficile diarrhoea
MS307 SPMS 55 M 19 20 MS
MS312 SPMS 68 F 24 23 Urinary sepsis
MS372 SPMS 82 F 7 46 Pneumonia
MS383 PPMS 42 M 17 8 Pneumonia
MS24 PPMS 71 F 96 22 Pneumonia
MS160 SPMS 44 F 18 16 Pneumonia
MS225 SPMS 79 F 23 32 MS, Diabetes mellitus, deep vein thrombosis
MS230 SPMS 42 F 31 19 MS
MS234 SPMS 39 F 15 15 Pulmonary embolism/Pneumonia
MS377 SPMS 50 F 22 23 Pneumonia
C21 C 91 F 127 N/A Pneumonia
C29 C 71 M 33 N/A Abdominal haemorrhage
C23 NC 93 F 51 N/A Alzheimer’s disease
C36 C 68 M 30 N/A Cryptogenic fibrosing alveolitis
C37 C 84 M 5 N/A Pneumonia, bladder cancer
C38 C 85 M 27 N/A Ischaemic heart disease
C39 C 82 M 21 N/A Myelodysplastic syndrome
C40 NC 86 F 29 N/A Acute cortical ischemic infarction
C41 C 54 M 20 N/A Lung cancer
NP7407-2 NC 93 F 24 N/A Acute cortical ischemic infarction
1228/91-b NC 88 F 24 N/A Acute cortical ischemic infarction
A140_07 NC 81 F 17 N/A Alzheimer’s disease
A173_08 NC 85 F 30 N/A Alzheimer’s disease
A192_2 NC 96 F 19 N/A Alzheimer’s disease
B5046-15 NC 42 M 72 N/A Herpes simplex encephalitis
B5125-9 NC 54 M 96 N/A Herpes simplex encephalitis
  1. SPMS: secondary progressive MS; PRMS: progressive relapsing MS; PPMS: primary progressive MS; NC: Neurological Control; C: non-neurological control with no known history of neurological disease; F: female; M: male; TPT: Tissue preservation time in hours; DD: disease duration.